A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker CodevelopmentSheila E. Taube(National Cancer Institute), Steven Gutman(CCS Associates (United States))JNCI Journal of the National Cancer InstituteOctober 23, 200910.1093/jnci/djp334Cited by 127SaveCiteExport RISWatch citationsRelated PapersReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration|PLoS Medicine|2012|1k